Pelthos Therapeutics
Price & Volume
Stats
See more52W Range | $4.50-$38 |
Shares Short | 0 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • last month
Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
Yahoo Finance • 2 months ago
Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
About
CEO | Mr. Scott M. Plesha |
Address | 4020 Stirrup Creek Drive, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
